Edwards Lifesciences Corp EW
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
Edwards Lifesciences Corp (EW) Core Market Data and Business Metrics
Latest Closing Price
$72.05Price-Earnings Ratio
10.40Total Outstanding Shares
585.76 Million SharesDividend
No dividendSIC Description
Orthopedic, Prosthetic & Surgical Appliances & SuppliesPrimary Exchange
New York Stock ExchangeHeadquarters
One Edwards Way, Irvine, CA, 92614
Historical Stock Splits
If you bought 1 share of EW before May 28, 2010, you'd have 12 shares today.
| Execution Date | Split Amount |
|---|---|
| June 1, 2020 | 3-for-1 |
| December 14, 2015 | 2-for-1 |
| May 28, 2010 | 2-for-1 |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 4,813,001 Shares | 1.96 | 3/14/2025 | 9,451,324 Shares |
| 4,080,021 Shares | 2.08 | 2/28/2025 | 8,486,888 Shares |
| 4,314,269 Shares | 2.76 | 2/14/2025 | 11,897,663 Shares |
| 5,269,416 Shares | 1.91 | 1/31/2025 | 10,049,082 Shares |
| 3,975,244 Shares | 2.27 | 1/15/2025 | 9,042,877 Shares |
| 5,819,626 Shares | 1.94 | 12/31/2024 | 11,310,531 Shares |
Cash Flow Statement
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Net Cash Flow, Continuing | $2.29 Billion |
| Net Cash Flow From Financing Activities | $-1.42 Billion |
| Net Cash Flow | $2.27 Billion |
| Net Cash Flow From Operating Activities, Continuing | $806.40 Million |
| Net Cash Flow From Financing Activities, Continuing | $-1.42 Billion |
| Net Cash Flow From Investing Activities, Continuing | $2.90 Billion |
Income Statement
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0 |
| Net Income/Loss Attributable To Noncontrolling Interest | $-3.80 Million |
| Operating Income/Loss | $1.64 Billion |
| Basic Earnings Per Share | $6.94 |
| Net Income/Loss | $4.16 Billion |
| Net Income/Loss Available To Common Stockholders, Basic | $4.16 Billion |
Comprehensive Income
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss Attributable To Parent | $4.16 Billion |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $-3.80 Million |
| Other Comprehensive Income/Loss | $-2.40 Million |
| Comprehensive Income/Loss | $4.15 Billion |
Balance Sheet
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Fixed Assets | $1.68 Billion |
| Liabilities | $3.36 Billion |
| Equity Attributable To Noncontrolling Interest | $65.80 Million |
| Inventory | $1.10 Billion |
| Assets | $12.97 Billion |
| Equity Attributable To Parent | $9.55 Billion |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||